Allan Doctor

Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL.

New York Blood Center, Inc. operates blood distribution and research organizations. It provides blood and blood products for transfusions annually. The company was founded in 1964 and is located in New York, NY.

Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE.

MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN.

St. Louis Arch Angels provides seed and early stage capital to the startup organizations. Its members mentor and coach, serve on boards, provide contacts, assist with team building, strategic planning and fundraising. The company was founded by Gilbert Bickel in January 2005 and is headquartered in Saint Louis, MO.

Kansas Bioscience Organization, Inc. is a non-profit organization, which engages in bioscience industry, academic research institutions, and economic development organizations. The company was founded in 2004 and is headquartered in Fairway, KS.

Regenerative Medicine Solutions engages in regenerative medicine solutions. It provides ProgenMix media formulation and RMS personalized consulting services. The company is headquartered in Madison, WI.

CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California.

Aronora, Inc. operates as an early clinical stage translational biopharmaceutical company. It researches and develops proprietary biological therapeutics. The company was founded by Andras Gruber and Erik I. Tucker and is headquartered in Portland, OR.

Rarebase, PBC is a biotech company that is dedicated to discovering and developing medicines for rare diseases. The company is based in Palo Alto, CA and was founded by Onno Faber and Omid Karkouti. The company has a product engine that is designed to discover treatments for hundreds of monogenic diseases simultaneously. Rarebase has already uncovered potential treatments for hundreds of rare diseases and has built a "drug-gene atlas" to enable AI-driven drug discovery. Onno Faber has been the CEO since incorporation.

Innsight Technology, Inc. offers bio engineering and eye diagnosis services. The company is based in Champaign, IL. The company was founded in 2014 by Leanne Labriola, Dipanjan Pan. Leanne Labriola has been the CEO since 2014.

RNA Disease Diagnostics is a Canadian company that aims to create a molecular diagnostic technology platform to prevent infectious disease transmission and improve global health. The private company is based in Toronto, Canada. The company plans to use its proprietary antisense RNA diagnostic platform to develop accurate, quick, affordable, and minimally invasive disease diagnostic testing kits for multiple diseases. RNA Disease Diagnostics' initial focus is on deploying COVID-19 antisense diagnostic point of care and home use test rapid diagnostic testing kits. The company was founded by Allan Grant Oberman.

Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020.

Thymmune Therapeutics is a preclinical biotechnology company located in the US that is developing a machine learning-enabled thymic cell engineering platform to restore normal immune function in aging and disease. The American company's approach in ipsc-thymic cell manufacturing can generate off-the-shelf cells at scale. Thymmune is developing a pipeline of therapies to treat immunodeficiencies, transplant-related, and autoimmune diseases. The company has strong IP positioning and is backed by early investors and founders of successful high-profile biotechnology companies.

NYBC Ventures (NYBC Ventures) is a venture capital subsidiary of New York Blood Center Inc founded in 2022. The firm is headquartered in Boston, Massachusetts.

Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA.